Antineoplastic reduces relapse rate, delays disability progression in progressive MS

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1170 / 1170
页数:1
相关论文
共 50 条
  • [1] The effect of pregnancy on relapse rate and disability progression in MS: results from the MSBase Registry
    Hughes, S. E.
    Spelman, T.
    Gray, O. M.
    Boz, C.
    Trojano, M.
    Zwanikken, C.
    Lugaresi, A.
    Izquierdo, G.
    Duquette, P.
    Girard, M.
    Grand'Maison, F.
    Grammond, P.
    Oreja-Guevara, C.
    Hupperts, R.
    Petersen, T.
    Bergamaschi, R.
    Giuliani, G.
    Lechner-Scott, J.
    Barnett, M.
    Rio, M. Edite
    van Pesch, V.
    Amato, M. P.
    Iuliano, G.
    Fiol, M.
    Slee, M.
    Verheul, F.
    Cristiano, E.
    Bolanos, R. Fernandez
    Poehlau, D.
    Saladino, M.
    Deri, N.
    Arruda, W. Oleschko
    Cabrera-Gomez, J. A.
    Paine, M.
    Vella, N.
    Herbert, J.
    Skromne, E.
    Savino, A.
    Shaw, C.
    Moore, F.
    Vucic, S.
    Petkovska-Boskova, T.
    Santiago, V.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S298 - S299
  • [3] Primary progressive MS (PPMS): Clinical characteristics and progression of disability
    Andersson, PB
    Waubant, E
    Gee, L
    Goodkin, DE
    NEUROLOGY, 1997, 48 (03) : 6076 - 6076
  • [4] Idebenone does not inhibit disability progression in primary progressive MS
    Kosa, Peter
    Wu, Tianxia
    Phillips, Jonathan
    Leinonen, Mika
    Masvekar, Ruturaj
    Komori, Mika
    Wichman, Alison
    Sandford, Mary
    Bielekova, Bibiana
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [5] Metabolomics associated with relapse rate and disability progression in relapse remitting multiple sclerosis patients
    Kitsos, D.
    Sideri, E.
    Chondrogianni, M.
    Tsivgoulis, A.
    Zompola, C.
    Thomaidis, N.
    Voumvourakis, K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 938 - 938
  • [6] Sick leave in early MS is associated with fatigue and relapse rate, not disability
    Doesburg, D.
    Mokkink, W.
    Vennegoor, A.
    Uitdehaag, B.
    van Oosten, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 368 - 368
  • [7] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
    Montalban, Xavier
    Cohen, Jeffrey A.
    Comi, Giancarlo
    Coyle, Patricia K.
    Kappos, Ludwig
    Li, Bingbing
    Sfikas, Nikolaos
    Willi, Roman
    Haring, Dieter A.
    Merschhemke, Martin
    Hauser, Stephen L.
    NEUROLOGY, 2020, 94 (15)
  • [8] Ofatumumab Reduces Disability Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis
    Kappos, Ludwig
    Montalban, Xavier
    Coyle, Patricia
    Nicholas, Jacqueline
    Meuth, Sven
    Li, Bingbing
    Ramanathan, Krishnan
    Su, Wendy
    Willi, Roman
    Haering, Dieter A.
    Hauser, Stephen
    NEUROLOGY, 2021, 96 (15)
  • [9] Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis
    Kappos, L.
    Wolinsky, J. S.
    Giovannoni, G.
    Arnold, D. L.
    Lublin, F.
    Wang, Q.
    Model, F.
    Wei, W.
    Garren, H.
    Manfrini, M.
    Belachew, S.
    Hauser, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 309 - 310
  • [10] Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
    Ribbons, Karen Ann
    McElduff, Patrick
    Boz, Cavit
    Trojano, Maria
    Izquierdo, Guillermo
    Duquette, Pierre
    Girard, Marc
    Grand'Maison, Francois
    Hupperts, Raymond
    Grammond, Pierre
    Oreja-Guevara, Celia
    Petersen, Thor
    Bergamaschi, Roberto
    Giuliani, Giorgio
    Barnett, Michael
    van Pesch, Vincent
    Amato, Maria-Pia
    Iuliano, Gerardo
    Fiol, Marcela
    Slee, Mark
    Verheul, Freek
    Cristiano, Edgardo
    Fernandez-Bolanos, Ricardo
    Saladino, Maria-Laura
    Rio, Maria Edite
    Cabrera-Gomez, Jose
    Butzkueven, Helmut
    van Munster, Erik
    Den Braber-Moerland, Leontien
    La Spitaleri, Daniele
    Lugaresi, Alessandra
    Shaygannejad, Vahid
    Gray, Orla
    Deri, Norma
    Alroughani, Raed
    Lechner-Scott, Jeannette
    PLOS ONE, 2015, 10 (06):